Senior insider sale
Chief Medical Officer at DENALI THERAPEUTICS INC. — senior position signals high conviction
$36.9K
1.65K shares
What this filing means
CHIN PETER SCOTT plans to sell 1.65K shares of DENALI THERAPEUTICS INC. valued at approximately $36.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/5/2026ACC: 0002124755-26-000006
Officer· Chief Medical Officer
Since Apr 2026
1.65K
Shares to sell
$36.9K
Approx. market value
1.65K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Lapse - See Remarks
Equity Compensation
9/3/2026
1.65KTotal acquired1.65K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/3/2026 | Restricted Stock Lapse - See Remarks Equity Compensation | 1.65K | — |
| Total | 1.65K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.65K
Market value
$36.9K
9/4/2026
Total
Units
1.65K
Value
$36.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/4/2026 | 1.65K | $36.9K | NASDAQ | Planned |
| Total | 1.65K | $36.9K | ||